# Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous Catheters

> **NCT00231153** · PHASE3 · COMPLETED · sponsor: **Cadence Pharmaceuticals** · enrollment: 1859 (actual)

## Conditions studied

- Infection

## Interventions

- **DRUG:** Omiganan 1% gel
- **DRUG:** Povidone-Iodine 10%

## Key facts

- **NCT ID:** NCT00231153
- **Lead sponsor:** Cadence Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2008-06
- **Final completion:** 2008-07
- **Target enrollment:** 1859 (ACTUAL)
- **Last updated:** 2009-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231153, "Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous Catheters". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00231153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*